High aromatase expression in uterine leiomyoma tissues of African-American women - sprookjes - yvandenbroek - TriplyDB

High aromatase expression in uterine leiomyoma tissues of African-American women

High aromatase expression in uterine leiomyoma tissues of African-American women

http://www.wikidata.org/entity/Q24658231

about

Aromatase inhibitors for uterine fibroids Aromatase inhibitors for uterine fibroids Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations Medical treatment of uterine leiomyoma Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis Uterine fibroids: current perspectives MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials.Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.Potential causes of subfertility in patients with intramural fibroids.The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells.Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop.Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Role of stem cells in human uterine leiomyoma growth.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.Changes in aromatase (CYP19) gene promoter usage in non-small cell lung cancer.MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?Uterine leiomyomas: individualizing the approach to a heterogeneous condition The role of progesterone signaling in the pathogenesis of uterine leiomyoma Surgical management of uterine fibroids at aminu kano teaching hospital.Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study.Innovative oral treatments of uterine leiomyoma Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.Use of alternative promoters may hide genetic effects on phenotypic traits Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays The health disparities of uterine fibroid tumors for African American women: a public health issue Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.Uterine fibroids: clinical manifestations and contemporary management.Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Redundant enhancers and causal variants in the TCF7L2 gene.Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma.Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.

P2860

Q24202922-104EA996-C2E5-48CA-B89F-EA52A978451C Q24234688-AFFA0123-AC71-44E6-8566-2F3B76543369 Q24563046-1CA23E6A-AF94-48C0-90F0-CB4D8801A526 Q24567733-75D81459-A968-406B-8047-32AB568D9465 Q26824379-A89710D3-E18D-4196-97BA-73E81E581126 Q29012930-7F1742E9-D2BC-41A7-BBF3-23F9BFA4492A Q30443242-2D64EF21-2249-4551-A56E-E34C700E6FB5 Q30852974-5035A33C-85EC-417E-82E1-8C4EE6064705 Q30875270-6379883D-4CED-4D52-BFF8-ACFE1DD9FB57 Q33654831-EDA45B16-64C7-4915-A637-7863F867E744 Q33857422-F10622E3-8DBA-4E16-8CAC-01FB66EB8813 Q34124951-9F58B704-F054-4553-B291-98BEADAC6CB8 Q34200701-DA9E19B3-D852-460A-B7EC-1CD355EA4339 Q34223004-F136502A-08E2-4A39-AD41-A2DBD63BBD62 Q34263429-9AFDB7C0-B02D-4F3C-8D11-7E84AA8A1BB0 Q34437666-05EF5F5C-F5C1-49BA-BBB8-3DDE688B0CCD Q35040111-C292B0E7-2278-4B1F-BABC-E5210D0A72FC Q35054425-E1FC2FAA-4F38-4325-9F98-F58A6B88C58B Q35140553-EF6E157E-1E3D-4B28-9CCE-F8CD83F7E308 Q35149373-2FD3D733-1219-455D-80E9-A1FF524EFEF6 Q35249360-367EE7B8-26FB-4CF6-B54F-95164375CC03 Q35550552-8E8A8367-0E0D-448F-92BC-B04BB80C5D9C Q35737921-C5A56E7F-D338-4491-BD53-065E04754E8C Q35837820-A6E4DAE6-DDC7-4BF9-9A6B-0655EE41B75C Q35855640-235070BF-27E8-4446-97A3-309FB04FD2E9 Q35944399-C4A9BF35-BECA-4C7B-B4EB-A566ED30FD3E Q36198889-6CDB9D44-4083-4E73-BA46-90F33F192D07 Q36224111-EE2C532F-E698-4A86-AB4F-6E6FA73988CA Q36511775-FA77F7FA-40B1-4A2F-9078-0CBBB6B8D09C Q36785182-CA07B2B2-DA89-4061-A082-5609A52DA518 Q37302324-ACADC966-6F00-489B-AC40-0E489F522CDF Q37416805-2A37E4CC-467F-4F30-ABD3-C42970D155A0 Q37417453-1DCA2383-1BE0-46B9-A0D0-E2B751E59A2A Q37681124-D7D57D00-1A1A-4A21-803C-9DD9F343C02F Q38211241-8CAE8524-FF01-469F-983F-8DA0D73C80FB Q38792320-CA7C8CD0-3FBE-4FC6-8B34-CC3B1F8CAC31 Q42835095-F461D333-B0E0-445B-AE64-1667CC0EA9DC Q43488978-D2373B88-FE8B-4457-A21F-9456C4B2E74D Q44005218-8630E8DF-3995-40AA-9155-B1E2DB17BE46 Q46560230-CC9D64E5-6F8A-465E-9092-C516029B7C64

P2860

High aromatase expression in uterine leiomyoma tissues of African-American women

http://www.wikidata.org/entity/Q24658231

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

High aromatase expression in uterine leiomyoma tissues of African-American women

@ast

High aromatase expression in uterine leiomyoma tissues of African-American women

@en

High aromatase expression in uterine leiomyoma tissues of African-American women

@nl

type

label

High aromatase expression in uterine leiomyoma tissues of African-American women

@ast

High aromatase expression in uterine leiomyoma tissues of African-American women

@en

High aromatase expression in uterine leiomyoma tissues of African-American women

@nl

prefLabel

High aromatase expression in uterine leiomyoma tissues of African-American women

@ast

High aromatase expression in uterine leiomyoma tissues of African-American women

@en

High aromatase expression in uterine leiomyoma tissues of African-American women

@nl

P1433

Q24658231-3D43A8E4-D1B3-46FD-B101-767E2AC67C19

P1476

Q24658231-CA592D3E-CE01-49A7-A730-64BC04E41AD4

P2093

Q24658231-267F8C03-AD15-4DB0-8554-FB8CC71D5A6D

Q24658231-66394D5B-E2EB-48C4-B96E-D117B7A5071B

Q24658231-8B28193B-BE09-488E-A0F2-425A0AE5C1FE

Q24658231-8CB55BC6-C8B1-4F7D-AB21-2413380A8E1B

Q24658231-A0470F6C-82C1-4611-80D5-5D377DA8D0F7

Q24658231-C63FECAC-3819-4E65-AFDD-BF7AC7A39B30

Q24658231-F90056C5-4CD4-45F1-8AEC-86D8E5EEB403

Q24658231-FA69D7A8-352C-409F-BFA2-D4D72210D909

P2860

Q24658231-06C8DDAB-197F-49C3-94F0-3F521AD59705

Q24658231-2295DE22-4B91-4EB9-9FE7-2F2F7FDF9313

Q24658231-29345B79-0386-4C87-A8F9-DBCAF36AEDC1

Q24658231-59CE01FF-F619-43DC-9970-2C4BC42B3568

Q24658231-65D2DAF1-9644-4CE0-8EBE-468402C2C6D3

Q24658231-719888A0-5907-4CAF-B619-21B485FB881E

Q24658231-B2F8DCD9-F339-4C3D-B3E0-2B883D40E3C0

Q24658231-B92E6D53-36D2-43FE-818B-0F7D147A4CEA

Q24658231-F63A8FB7-2EFD-4A74-83BB-F3B366C4308C

Q24658231-F7B2EFA9-9EAC-4647-AA47-A818856399D3

P304

Q24658231-7B22BE9A-B249-40EC-8949-2ED3905EB56A

P31

Q24658231-1457423B-EA41-4B30-826D-FA3DEA09374E

P356

Q24658231-466D7994-B486-463A-BFA9-4F44F7E73A2B

P407

Q24658231-CC7FEDA6-E204-4C6F-8BD9-B784615D4BEB

P433

Q24658231-AAFF0C27-CAC7-4AFB-A2AE-008EC46D4042

P478

Q24658231-DA78F551-9B57-4F35-91D7-722FD18BC1F8

P50

Q24658231-65D518D9-241E-4F40-9904-9845A46F5010

P577

Q24658231-C577CD13-1FAA-4A92-B302-2AE6617D4E66

P698

Q24658231-DCCD24E4-EF3F-43D0-8FB7-555F668693E2

P932

Q24658231-97F99A5C-901B-4659-8C76-463403336DBF

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

High aromatase expression in uterine leiomyoma tissues of African-American women

@en

P2093

Alfred W Rademaker

http://www.w3.org/2001/XMLSchema#string

Hirokazu Usui

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

Makio Shozu

http://www.w3.org/2001/XMLSchema#string

Masaki Inoue

http://www.w3.org/2001/XMLSchema#string

Scott Reierstad

http://www.w3.org/2001/XMLSchema#string

Serdar E Bulun

http://www.w3.org/2001/XMLSchema#string

Tadayuki Kasai

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).

Novel promoter I.8 and promoter usage in the CYP19 (aromatase) gene.

Uterine fibroids.

Molecular genetics and racial disparities of uterine leiomyomas

Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.

CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma.

Etiology, symptomatology, and diagnosis of uterine myomas.

Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.

Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.

P304

1752-1756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-2327

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19240151

http://www.w3.org/2001/XMLSchema#string

P932

2684481

http://www.w3.org/2001/XMLSchema#string